PMC full text:

Table 2

Echocardiographic findings of the study population stratified by AR severity

No AR (n = 7007)Mild AR (n = 932)Moderate/Severe AR (n = 228)p-value
Concomitant valvular disease
 Mild AS86 (1.3)23 (2.8)7 (3.4) < 0.001
 Moderate/severe MR189 (2.3)74 (7.9)19 (8.3) < 0.001
 Moderate/severe TR623 (8.9)193 (20.7)46 (20.2) < 0.001
Echocardiographic data
 LVEF 2D, %58.5 ± 5.258.3 + 5.057.6 ± 5.60.045
 LVEF 3D, %59.6 ± 6.859.2 ± 6.658.3 ± 6.80.178
 LVEDD, mm47.7 ± 5.247.9 ± 5.348.9 ± 6.40.004
 LVEDV, ml114.9 ± 31.8108.4 ± 30.6118.9 ± 34.6 < 0.001
 TAPSE, mm24.4 ± 4.323.8 ± 4.423.4 ± 4.20.001
 RV FAC, %43.2 ± 8.043.7 ± 7.742.7 ± 8.40.217
 IVSD, mm9.9 ± 1.710.3 ± 1.810.7 ± 1.9 < 0.001
 E/e ‘7.6 ± 2.17.8 ± 2.48.5 ± 2.9 < 0.001
 LAVI, ml/m227.5 ± 8.427.9 ± 8.930.2 ± 10.8 < 0.001
 LA Global Peak strain, %39.8 ± 14.438.5 ± 15.437.0 ± 14.50.014

Data are given as n (%) or mean ± standard deviation, p-value for intergroup differences. All subjects with moderate/severe aortic stenosis or bicuspid valves were excluded from the analysis

AS aortic stenosis, IVST interventricular septum thickness, LA left atrial, LAVI left atrial volume index, LVEDD left ventricular end-diastolic diameter, LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection fraction, MR mitral regurgitation, MS mitral stenosis, RV FAC right ventricular fractional area change, TAPSE tricuspid annular peak systolic excursion, TR tricuspid regurgitation